采用酶联免疫吸附试验、流式细胞术、放射配体结合试验及蛋白质印迹等方法,首次证实了人T细胞系Jurkat表达特异性C1q受体,并对其特性进行了分析Jurkat可为C1q或抗人C1q受体抗体112识别,其对异硫氰酸荧光黄标记C1q的结合能被未标记C1q所抑制.在生理离子强度和温度条件下,Jurkat与 125I-C1q的结合呈持异、剂量依赖、可饱和及可逆性,每个细胞C1q结合位点数为1.1×106,对C1q的Ka值为1.5×107mol-1,Hill系数为0.9643.Jurkat C1q受体识别C1q的胶原样区.该受体是分子量约70000的膜蛋白分子
The C1q receptor (C1qR) on the human T lymphocyte line Jurkat cells was demonstrated and characterized. Cell-ELISA showed that Jurkat cells are able to bind exogenous C1q and recognized by the anti-C1qRantibody 112. FCM analysis indicated that the binding of FITC-C1q to Jurkat cells is blocked by an excess of unlabelled C1q.Quantitative binding studies with monomeric 125I-C1q showed a specific, dose-dependent,saturable and reversible binding involving specific membrane receptors on Jurkat cells, Goldstein analysis and Hill plot of C1q binding showed 1.1×106 binding sites per cell with an average affinity of 1.5×107mol-1 and a Hill number of 0.9643 at normal ionic strength(I=0 .15) and temperature(37℃). The experiment with the anti-Clq monoclonal antibody A4,which recognizes the collagen-like region (CLR) of C1q, established that it is via its CLR that C1q binds to Jurkat cell receptors. Western blotting with the anti-C1qR antibody 112 revealed that the C1qR on Jurkat cells is a membrane protein of 70 ku.
陈政良,谢佩蓉.人T细胞系Jurkat表达特异性的C1q受体[J].生物化学与生物物理进展,1996,23(2):164-168
复制生物化学与生物物理进展 ® 2025 版权所有 ICP:京ICP备05023138号-1 京公网安备 11010502031771号